A detailed history of O'Neil Global Advisors, Inc. transactions in Trans Medics Group, Inc. stock. As of the latest transaction made, O'Neil Global Advisors, Inc. holds 10,812 shares of TMDX stock, worth $710,456. This represents 0.43% of its overall portfolio holdings.

Number of Shares
10,812
Previous 10,649 1.53%
Holding current value
$710,456
Previous $1.6 Million 5.8%
% of portfolio
0.43%
Previous 0.75%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$135.68 - $176.11 $22,115 - $28,705
163 Added 1.53%
10,812 $1.7 Million
Q2 2024

Aug 08, 2024

BUY
$72.62 - $150.62 $773,330 - $1.6 Million
10,649 New
10,649 $1.6 Million

Others Institutions Holding TMDX

About TransMedics Group, Inc.


  • Ticker TMDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 31,831,400
  • Market Cap $2.09B
  • Description
  • TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and custo...
More about TMDX
Track This Portfolio

Track O'Neil Global Advisors, Inc. Portfolio

Follow O'Neil Global Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of O'Neil Global Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on O'Neil Global Advisors, Inc. with notifications on news.